1. SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
   Chen Xiuju et al, 2016, Open Medicine CrossRef
2. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature
   Safwan Alomari et al, 2021, Biomolecules CrossRef
3. Drug Repositioning in Glioblastoma: A Pathway Perspective
   Sze Kiat Tan et al, 2018, Frontiers in Pharmacology CrossRef
4. Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level
   Michal Taler et al, 2022, International Journal of Molecular Sciences CrossRef
5. Antidepressant Drug Sertraline against Human Cancer Cells
   Diana Duarte et al, 2022, Biomolecules CrossRef
6. Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis
   Kao-Hui Liu et al, 2015, Oncotarget CrossRef
7. Effect of Selected Anionic and Cationic Drugs Affecting the Central Nervous System on Electrical Properties of Phosphatidylcholine Liposomes: Experiment and Theory
   Joanna Kotyńska et al, 2021, International Journal of Molecular Sciences CrossRef
8. Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review
   Muhamad N.A. Kamarudin et al, 2019, Oncotarget CrossRef
9. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
   Richard E. Kast et al, 2014, Oncotarget CrossRef
10. A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
    Richard E. Kast et al, 2013, Oncotarget CrossRef
11. Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia
    Timothy Johanssen et al, 2023, Frontiers in Oncology CrossRef